Furthermore, we validated our findings using highly relevant CRC clinical samples and investigated the clinical data to determine the relationship between the number of PGCCs, percentage of vimentin nuclear positivity, and degree of tumor differentiation. This evidence concerns the gene VIM and colorectal carcinoma.